{"id":16080,"date":"2023-02-10T00:31:30","date_gmt":"2023-02-09T23:31:30","guid":{"rendered":"https:\/\/www.upjs.sk\/lekarska-fakulta\/vyskum-na-fakulte\/vedecke-projekty\/moimed\/"},"modified":"2023-02-10T00:37:27","modified_gmt":"2023-02-09T23:37:27","slug":"moimed","status":"publish","type":"page","link":"https:\/\/www.upjs.sk\/lekarska-fakulta\/vyskum-na-fakulte\/vedecke-projekty\/ine-projekty\/eu-ostatne\/moimed\/","title":{"rendered":"Centrum v\u00fdskumu inovat\u00edvnych terapeutick\u00fdch postupov molekul\u00e1rnej medic\u00edny"},"content":{"rendered":"
Projekt \u201eMolMed\u201c vznikol v spolupr\u00e1ci s firmou SEMBID, s.r.o. a LF UPJ\u0160, ktor\u00e9 sa na jeho realiz\u00e1cii podie\u013eaj\u00fa spolo\u010dne.<\/p>\n
Hlavn\u00e9 aktivity projektu s\u00fa:<\/strong><\/p>\n Aktivita 1.1<\/em> Zriadenie a vedeck\u00fd mana\u017ement spolo\u010dn\u00e9ho v\u00fdskumn\u00e9ho centra pre oblas\u0165 molekul\u00e1rnej medic\u00edny<\/em>, kde hlavn\u00fdm cie\u013eom je definova\u0165 dlhodob\u00fd strategick\u00fd v\u00fdskumn\u00fd pl\u00e1n centra a vytvorenie funk\u010dn\u00fdch v\u00e4zieb medzi jednotliv\u00fdmi pracoviskami v r\u00e1mci centra tak, aby efekt\u00edvne fungovalo ako jeden celok pod\u013ea vzoru popredn\u00fdch zahrani\u010dn\u00fdch a medzin\u00e1rodn\u00fdch v\u00fdskumno-v\u00fdvojov\u00fdch centier.<\/p>\n Aktivita 2.1 V\u00fdskum inovat\u00edvnej siRNA technol\u00f3gie vyu\u017eite\u013enej v terapii \u0161pecifick\u00fdch hematoonkologick\u00fdch ochoren\u00ed<\/em>, kde hlavn\u00fdm cie\u013eom je dospie\u0165 k re\u00e1lnym poznatkom, ktor\u00fdch uplatnenie v praxi by smerovalo k etablovaniu nov\u00fdch terapeutick\u00fdch pr\u00edstupov \u0161pecifick\u00fdch onkohematologick\u00fdch ochoren\u00ed typu chronickej myeloidnej leuk\u00e9mie (CML), ak\u00fatnej lymfoblastickej leuk\u00e9mie (ALL). V\u00fdskum na \u00farovni ich gen\u00f3mu a prote\u00f3mu bude \u010falej sl\u00fa\u017ei\u0165 pre identifik\u00e1ciu biomarkerov neoplastickej transform\u00e1cie. Cie\u013eov\u00fdmi skupinami s\u00fa onkohematologick\u00ed pacienti.<\/p>\n Podporn\u00e9 aktivity projektu:<\/strong><\/p>\n Riadenie projektu Za\u010diatok realiz\u00e1cie projektu a v\u0161etk\u00fdch aktiv\u00edt je III\/2012, koniec realiz\u00e1cie projektu je pl\u00e1novan\u00fd IV\/2014.<\/p>\n Inform\u00e1cie pre rie\u0161ite\u013eov projektu:<\/strong><\/p>\n D\u0148a 21.3.2013 o\u00a013,00 hod., na \u00dastave lek\u00e1rskej a\u00a0klinickej biofyziky sa uskuto\u010dn\u00ed v\u00a0r\u00e1mci projektu MolMed odborn\u00fd semin\u00e1r:<\/strong><\/span><\/p>\n \u201eChronick\u00e1 myelocytov\u00e1 leuk\u00e9mia – od genetiky k\u00a0proteomike\u201c.<\/em><\/strong><\/span><\/p>\n Predn\u00e1\u0161aj\u00faci: prof. MUDr. Elena T\u00f3thov\u00e1, CSc., rie\u0161ite\u013e aktivity 2.1.<\/strong><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n \u00a0<\/strong><\/p>\n Harmonogram pod\u00e1vania \u017eiadost\u00ed o\u00a0platu a\u00a0monitorovac\u00edch spr\u00e1v na rok 2013: <\/strong><\/p>\n Projekt \u201eMolMed\u201c vznikol v spolupr\u00e1ci s firmou SEMBID, s.r.o. a LF UPJ\u0160, ktor\u00e9 sa na jeho realiz\u00e1cii podie\u013eaj\u00fa spolo\u010dne. Hlavn\u00e9 aktivity projektu s\u00fa: Aktivita 1.1 Zriadenie a vedeck\u00fd mana\u017ement spolo\u010dn\u00e9ho v\u00fdskumn\u00e9ho centra pre oblas\u0165 molekul\u00e1rnej medic\u00edny, kde hlavn\u00fdm cie\u013eom je definova\u0165 dlhodob\u00fd strategick\u00fd v\u00fdskumn\u00fd pl\u00e1n centra a vytvorenie funk\u010dn\u00fdch v\u00e4zieb medzi jednotliv\u00fdmi pracoviskami v r\u00e1mci … \u010c\u00edta\u0165 \u010falej<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":16032,"menu_order":5,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":1,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","footnotes":""},"class_list":["post-16080","page","type-page","status-publish","hentry"],"acf":{"acf_link_na_externy_obsah":""},"yoast_head":"\n
\nPublicita a informovanos\u0165<\/p>\n\n\n
\n \n \n\n
\n Harmonogram pod\u00e1vania \u017eiadost\u00ed o\u00a0platbu sa vykon\u00e1va v\u00a0dvojmesa\u010dn\u00fdch intervaloch v\u00a0nasledovn\u00fdch term\u00ednoch:<\/td>\n 12.4.2013,\u00a0 12.6.2013, 12.8.2013, 11.10.2013, 12.12.2013<\/strong><\/td>\n<\/tr>\n \n Harmonogram pod\u00e1vania monitorovac\u00edch spr\u00e1v sa vykon\u00e1va v\u00a0\u0161es\u0165mesa\u010dn\u00fdch intervaloch v\u00a0nasledovn\u00fdch term\u00ednoch:<\/td>\n 15.4.2013, 15.10.2013<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"